Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have no recent searches
The 340B drug purchasing program has friends and more friends, but don’t count the Community Oncology Alliance (COA) among them.
The 340B program allows some hospitals, hospital-owned physician practices and community health centers to buy drugs for much less than most hospitals and independent physician practices can. That seems like a good idea unless you are in the pharmaceutical industry or the Office of Inspector General or an organization that represents oncology practices that do not get 340B pricing.
COA commissioned a report (free registration required), released this week, that says the 340B pricing program has actually increased the cost of cancer care. The research, conducted by Berkeley Research Group, fuels the argument of those who say 340B pricing prompts hospitals to buy oncology practices so they can make profits on chemotherapy.
The researchers report that at least 120 hospitals with 340B pricing acquired one or more independent oncology practices between 2009 and 2012. Because the cost of cancer care delivered in hospitals is more expensive than in physician-owned practices, the analysts estimate that the Medicare program paid $23 million more and Medicare patients paid $4 million more for cancer care than they would have if those practices had remained independent.
Meanwhile, those who think the 340B program is unfair met this week in Washington to discuss the program. And 340B supporters said that meeting was no fun.
Subscribe to this Blog's RSS Feed
Lola ButcherLOLA BUTCHER, MPA, MA, an award-winning Contributing Writer for Oncology Times, writes about health policy and business trends. She is a frequent contributor to Hospitals & Health Networks, Modern Physician, Neurology Today, and other health care trade publications. This blog was recently recognized with an APEX Award for Publication Excellence.
Friend's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at Oncology Times.
Send a copy to your email
Your message has been successfully sent to your friend.
Some error has occurred while processing your request. Please try after some time.